Mechanism of action of therapeutic levels of cardiac glycosides.
D000818:Animals; D001665:Binding Sites; D002301:Cardiac Glycosides / Q000097:blood / Q000494:pharmacology* / Q000627:therapeutic use; D002715:Chlormadinone Acetate / Q000494:pharmacology; D006321:Heart / Q000187:drug effects; D006801:Humans; D066298:In Vitro Techniques; D008564:Membrane Potentials / Q000187:drug effects; D009200:Myocardial Contraction / Q000187:drug effects; D009206:Myocardium / Q000378:metabolism; D011188:Potassium / Q000378:metabolism; D012413:Rubidium / Q000378:metabolism; D012964:Sodium / Q000378:metabolism; D000254:Sodium-Potassium-Exchanging ATPase / Q000378:metabolism; D014639:Vanadium / Q000494:pharmacology
D002301:Cardiac Glycosides; D014639:Vanadium; D002715:Chlormadinone Acetate; D012964:Sodium; D000254:Sodium-Potassium-Exchanging ATPase; D012413:Rubidium; D011188:Potassium